Condition
C-KIT Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 C-KIT Mutation clinical trials that are recruiting, at sites in 2 countries (most in China (1), France (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using Avapritinib to treat relapsed or refractory pediatric CBF-AML with KIT mutation
This study is testing if a new drug called avapritinib can help children with a specific type of leukemia that keeps coming back and has a certain mutation, to see if it works better than the treatments they currently have.
-
Evaluating Imatinib Treatment After 10 Years for GIST Patients
This study is testing whether stopping or continuing imatinib treatment helps people with advanced gastrointestinal stromal tumors who have been on the medication for at least 10 years.
Related topics
Quick answers
How many C-KIT Mutation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.